The aim of the study is to investigate the effectiveness of schema therapy in older adults with BPD.
ID
Source
Brief title
Condition
- Manic and bipolar mood disorders and disturbances
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome measure is the credibility of personal, negative core
beliefs, which are measured weekly.
Secondary outcome
Secondary outcome measures are quality of life, psychological distress, early
maladaptive schemas, schema modes, severity of BPD symptoms and meeting the
criteria for BPD.
Background summary
The treatment of BPD in younger adults has been examined extensively in the
past quarter of a century, but there is still a world to discover in treating
BPD in older adults. Until 2017, no studies had been published into the
treatment of personality disorders in older adults as the main focus of
treatment.
Study objective
The aim of the study is to investigate the effectiveness of schema therapy in
older adults with BPD.
Study design
A multiple baseline design will be used with baseline varying from 4 to 8
weeks. Participants are randomly assigned to baseline length. During baseline
no therapeutic interventions will be applied. The next phase consists of ST for
BPD and lasts 52 weeks. The final phase is a follow up phase which includes six
monthly booster sessions to maintain the effects of ST.
Intervention
Schema therapy
Study burden and risks
Schema therapy is proven effective in adults with BPD. Schema therapy is
becoming more common practice in the treatment of older adults with BPD. A
recent study showed that ST is an effective treatment for older adults with
other personality disorders then borderline.
The extra effort asked of participants in comparison to treatment as usual has
been minimalized.
In our view participants are not exposed to risks and could profit from the
intervention under study.
Professor Cobbenhagenlaan 125
Tilburg 5037DB
NL
Professor Cobbenhagenlaan 125
Tilburg 5037DB
NL
Listed location countries
Age
Inclusion criteria
1) a primary diagnosis of BPD, assessed with the Structured Clinical Interview for DSM-5 Personality disorders
2) increased scores on the traits negative affectivity, disinhibition, and psychoticism of the Personality Inventory for DSM-5
3) absence of chronic somatic comorbidity which seriously affects daily life functioning
4) minimum age of 60 years
5) willingness to participate in the study.
Exclusion criteria
1) Severe depression
2) Bipolar disorder
3) Psychotic disorder (other than transient stress-related psychosis, if this overlaps with criterion 9 of BPD)
4) IQ under 80
5) Substance dependence that needs clinical detoxification
6) Neurocognitive disorder expressed by a MMSE-score below 25
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL65141.028.18 |